---
schema_version: "secwatch.filing_event.v1"
accession: "0000318154-22-000053"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:02:23.214246+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amgen Q3: GAAP EPS $3.98, non-GAAP $4.70; revenue $6.7B (-1%); volumes +8%; FY22 rev guide $26.0-26.3B

## Summary
- GAAP EPS $3.98 (up from $3.31); non-GAAP EPS $4.70 (up from $4.08).
- Total revenues $6.7B, down 1% YoY; product sales volumes grew 8%, offset by 5% lower net price and 2% FX headwind.
- Free cash flow $2.8B in Q3 versus $2.2B in prior year.
- FY 2022 revenue guidance revised to $26.0-26.3B; GAAP EPS $11.46-12.17; non-GAAP EPS $17.25-17.85.
- Non-GAAP policy changed: upfront license fees no longer excluded; Q3 2021 non-GAAP EPS recast downward by $0.59.

## SEC filing metadata
- accession: 0000318154-22-000053
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000031815422000053/0000318154-22-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000031815422000053/amgn-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000318154-22-000053
- JSON: https://secwatch.observer/filing/0000318154-22-000053.json
- Plain text: https://secwatch.observer/filing/0000318154-22-000053.txt

## Key facts
- Earnings Releases
  AMGEN INC reported third quarter of 2022 results: revenue $6.7 billion. Guidance lowered.
  - Period: third quarter of 2022
  - Revenue: $6.7 billion
  - Guidance: lowered
  - Result: reported results
  source text: Total revenues decreased 1% to $6.7 billion in comparison to the third quarter of 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/318154/000031815422000053/0000318154-22-000053-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.